S-EPMC12311575 - Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among individuals aged 5–80 years in India: a phase 3, single-blind, randomised controlled trial - OmicsDI

Unknown

Dataset Information

Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among individuals aged 5–80 years in India: a phase 3, single-blind, randomised controlled trial

ABSTRACT:

SUBMITTER: Thuluva S

PROVIDER: S-EPMC12311575 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature